Oh really?
It's very unusual for BIT to call a trading halt, and this is their first pause in trading.
Considering the sensitive nature of their research this year - news has been restricted for non-disclosure reasons, and the recent appointment of the CMO to advance their HIV tests to commercialisation, I would guess this is an announcement of huge importance.
BIT is well funded with a decent cash balance and will be in receipt of further Government grants, so this is not a trading halt for a CR.
Ann: Pause in Trading, page-81
-
- There are more pages in this discussion • 172 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
